The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE
申请人:NOVO NORDISK A/S
公开号:EP0682657A1
公开(公告)日:1995-11-22
US5468748A
申请人:——
公开号:US5468748A
公开(公告)日:1995-11-21
US5646146A
申请人:——
公开号:US5646146A
公开(公告)日:1997-07-08
[EN] HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE<br/>[FR] COMPOSES HETEROCYCLIQUES, LEUR PREPARATION ET LEUR UTILISATION
申请人:NOVO NORDISK A/S
公开号:WO1994018175A1
公开(公告)日:1994-08-18
(EN) Novel 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in the treatment of neurological and psychiatric diseases.(FR) Nouvelles 9H-indéno[1,2-b]pyrazine-3(4H)-ones et 9H-indéno[1,2-b]pyrazine-2,3(1H,4H)-diones ou formes tautomères de celles-ci, pouvant être utlisées pour le traitement d'affections d'ordre neurologique ou psychiatrique.